Search results for: France
Filter search results
Incentives, Competition, and Pharmaceutical Innovation in Europe: The Case of Direct Acting Antivirals for Hepatitis C
26 July 2018
…curves and market shares demonstrate that access to DAAs was sped up in this second stage for Germany, Spain, Italy and Portugal. For France, access was already high at this…
Approaches, Challenges and Successful Stories of Multi-indication Pricing in Europe
28 November 2018
…(Netherlands, Norway and Poland), a single price ‘weighted’ by the value of each indication (Germany, France, Belgium and Austria) or individual prices for each indication (Italy). De facto, only the…
OHE at the 2019 Spanish Health Economics Association (AES) Conference
5 June 2019
…result is of the highest importance; responses from the UK, France, Spain, and Italy showed convenience as the most important attribute. Confidence and convenience were jointly favoured by respondents in…
Data Governance Arrangements for Real-world Evidence in Japan
12 September 2019
…and to see whether use is aligned with international standards. A 2015 OHE Consulting Report explored data governance arrangements for real-world evidence (RWE) in eight countries: Australia, France, Germany, Italy,…
A Market-based International Reference Price Index: Solution or Contradiction?
13 September 2019
…the Netherlands, France, and Austria) is used in Switzerland. Singapore is beginning to implement a value-based pricing framework, but most drugs are purchased through a centralised procurement office. Regulation through…
OHE at HTAi 2017: Meet the Team
13 June 2017
…This study compares the availability and access to orphan medicinal products in the UK (England, Scotland and Wales), France, Germany, Italy and Spain. Orphan drugs are authorised in all EU…
HTA and Payment Mechanisms for New Drugs to Tackle AMR
23 September 2019
…of the current state of HTA and contracting for antibiotics in France, Germany, Italy, Sweden, and the UK (England and Scotland), and of the recent proposals in the literature for…
Press Release: Proposed International Price Index Effectively Outsources Pharmaceutical Policy Decisions to Other Countries
29 October 2019
…SW1E 6QT ohegeneral@ohe.org For interview requests, please contact atowse@ohe.org Notes to Editors: [1] The Trump Administration proposal would compare the U.S. to the other G7 countries (Canada, France, Germany, Italy,…
OHE at HESG Winter 2020
2 January 2020
…improve care-related quality of life in England? 09:30 – 10:25, Rocket Author: Francesco Longo Chair: Stavros Petrou. Discussant: Chris Sampson. The role of GPs risk attitudes and personalities in the…